Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GART | P22102 | 10/20 | 0.79 |
| ▸ | FOLR1 | P15328 | 7/20 | 0.79 |
| ▸ | SLC46A1 | Q96NT5 | 7/20 | 0.79 |
| ▸ | TYMS | P04818 | 6/20 | 0.79 |
| ▸ | SLC19A1 | P41440 | 6/20 | 0.79 |
| ▸ | DHFR | P00374 | 4/20 | 0.79 |
| ▸ | FOLR2 | P14207 | 3/20 | 0.79 |
| ▸ | ATIC | P31939 | 2/20 | 0.79 |
| ▸ | SHMT1 | P34896 | 1/20 | 0.79 |
| ▸ | FRK | P42685 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25498348 | 1.00 | GART (0.79) | GARTFOLR1SLC46A1TYMSSLC19A1 | |
| SCHEMBL15078861 | 0.92 | GART (0.84) | GARTFOLR1SLC46A1TYMSSLC19A1 | |
| SCHEMBL25899260 | 0.90 | GART (0.82) | GARTFOLR1SLC46A1TYMSSLC19A1 | |
| SCHEMBL25498175 | 0.89 | GART (0.79) | GARTFOLR1SLC46A1TYMSSLC19A1 | |
| SCHEMBL25498255 | 0.89 | GART (0.79) | GARTFOLR1SLC46A1TYMSSLC19A1 | |
| SCHEMBL19758225 | 0.88 | GART (0.87) | GARTFOLR1SLC46A1TYMSSLC19A1 | |
| Pemetrexed SCHEMBL7144918 | 0.88 | GART (1.00) | GARTFOLR1SLC46A1TYMSSLC19A1 | |
| Pemetrexed SCHEMBL5959741 | 0.88 | GART (1.00) | GARTFOLR1SLC46A1TYMSSLC19A1 | |
| Pemetrexed SCHEMBL209720 | 0.88 | GART (1.00) | GARTFOLR1SLC46A1TYMSSLC19A1 | |
| SCHEMBL24413672 | 0.88 | GART (0.85) | GARTFOLR1SLC46A1TYMSSLC19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021262693-A1 | METHOTREXATE ANALOGS AND METHODS OF USE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2021-12-30 | — | — | WO | disclosed |